Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07358585
What this trial is testing

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer Adenocarcinoma
Shanghai Henlius Biotech 126
Testing effectiveness (Phase 2)UnknownNCT04571489
What this trial is testing

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Lee's Pharmaceutical Limited 60
Testing effectiveness (Phase 2)Ended earlyNCT00539617
What this trial is testing

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 7
Not applicableLooking for participantsNCT07067138
What this trial is testing

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Ended earlyNCT03952325
What this trial is testing

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 294
Early research (Phase 1)Ended earlyNCT04892017
What this trial is testing

Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerAdvanced Solid TumorMetastatic Solid Tumor
Deciphera Pharmaceuticals, LLC 91
Not applicableStudy completedNCT04187768
What this trial is testing

Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticHealthy
Indiana University 29
Testing effectiveness (Phase 2)Study completedNCT00113529
What this trial is testing

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer 42
Early research (Phase 1)Temporarily pausedNCT05938296
What this trial is testing

OHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Who this might be right for
Solid Tumor
Binhui Biopharmaceutical Co., Ltd. 29
Testing effectiveness (Phase 2)Ended earlyNCT02089802
What this trial is testing

Optimizing Pazopanib Exposure in RCC Patients

Who this might be right for
Locally Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e. 6
Testing effectiveness (Phase 2)Study completedNCT00077402
What this trial is testing

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Therapeutics Research Group 50
Testing effectiveness (Phase 2)Ended earlyNCT02000596
What this trial is testing

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Who this might be right for
Metastatic Breast Cancer
University of Maryland, Baltimore 2
Not applicableUnknownNCT00792896
What this trial is testing

Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease

Who this might be right for
Advanced CancerMetastatic Cancer
National Taiwan University Hospital 150
Early research (Phase 1)Looking for participantsNCT07181473
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Lung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more
Phrontline Biopharma 200
Testing effectiveness (Phase 2)Study completedNCT00234403
What this trial is testing

A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 60
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Not applicableStudy completedNCT04308356
What this trial is testing

Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status?

Who this might be right for
Neoplasm MetastasisLocoregional NeoplasmAdvanced Cancer
Assistance Publique - Hôpitaux de Paris 71
Early research (Phase 1)Study completedNCT00462956
What this trial is testing

GW572016 In Patients With Advanced Or Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 59
Early research (Phase 1)WithdrawnNCT05828303
What this trial is testing

Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
Turning Point Therapeutics, Inc.
Not applicableStudy completedNCT01725386
What this trial is testing

An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 274
Next Page